Chengmu Hu

1.1k total citations
33 papers, 848 citations indexed

About

Chengmu Hu is a scholar working on Epidemiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Chengmu Hu has authored 33 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Molecular Biology and 8 papers in Cell Biology. Recurrent topics in Chengmu Hu's work include Liver Disease Diagnosis and Treatment (13 papers), Caveolin-1 and cellular processes (8 papers) and Lipid metabolism and disorders (6 papers). Chengmu Hu is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Caveolin-1 and cellular processes (8 papers) and Lipid metabolism and disorders (6 papers). Chengmu Hu collaborates with scholars based in China, Hong Kong and Australia. Chengmu Hu's co-authors include Wenming Cheng, Jun Li, Tianpa You, Li Cai, Liying Tang, Yan Huang, Yi Chen, Rong Li, Lei Zhang and Jun Li and has published in prestigious journals such as The FASEB Journal, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Chengmu Hu

32 papers receiving 818 citations

Peers

Chengmu Hu
Mi‐Young Jeong South Korea
Joe Eun Son South Korea
Young-Suk Jung South Korea
Xin Han China
Mamdouh M. El‐Shishtawy Egypt
Jinbong Park South Korea
Laila A. Eissa Egypt
Yuki Kawakami Japan
Zhenping Zhu China
Yun-Hee Lee South Korea
Mi‐Young Jeong South Korea
Chengmu Hu
Citations per year, relative to Chengmu Hu Chengmu Hu (= 1×) peers Mi‐Young Jeong

Countries citing papers authored by Chengmu Hu

Since Specialization
Citations

This map shows the geographic impact of Chengmu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengmu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengmu Hu more than expected).

Fields of papers citing papers by Chengmu Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengmu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengmu Hu. The network helps show where Chengmu Hu may publish in the future.

Co-authorship network of co-authors of Chengmu Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengmu Hu. A scholar is included among the top collaborators of Chengmu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengmu Hu. Chengmu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Ning, Liang Shan, Yehuan Sun, et al.. (2025). Caveolin-1 protects against liver injury and lipid accumulation in alcoholic fatty liver via ferroptosis resistance. Molecular Immunology. 181. 53–65. 2 indexed citations
2.
Guo, Ning, Qianqian Geng, Yong Wang, et al.. (2025). Paeoniflorin Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease by Targeting STING-Mediated Pyroptosis via Inhibiting the NLRP3 Inflammasome. The American Journal of Chinese Medicine. 53(5). 1521–1543. 1 indexed citations
3.
Lin, Huimin, Xu Zhou, Zihao Li, et al.. (2024). A novel experimental mouse model of diabetic nonalcoholic steatohepatitis: A critical role for acid-sensitive Ion Channel 1a. Biomedicine & Pharmacotherapy. 178. 117184–117184.
4.
5.
Wu, Shuai, Ning Guo, Yu Li, et al.. (2024). Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway. Biochemical Pharmacology. 230(Pt 2). 116594–116594. 10 indexed citations
6.
Li, Bowen, Lili Wang, Huimin Lin, et al.. (2023). Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatitis. The FASEB Journal. 37(6). e22965–e22965. 15 indexed citations
7.
Wu, Shuai, et al.. (2023). A narrative review of the role of exosomes and caveolin-1 in liver diseases and cancer. International Immunopharmacology. 120. 110284–110284. 8 indexed citations
8.
Li, Yu, Shuai Wu, Xin Jiao, et al.. (2022). Caveolin-1 ameliorates acetaminophen-aggravated inflammatory damage and lipid deposition in non-alcoholic fatty liver disease via the ROS/TXNIP/NLRP3 pathway. International Immunopharmacology. 114. 109558–109558. 21 indexed citations
9.
Jiao, Xin, Wei Jiang, Xiaowen Feng, et al.. (2022). Caveolin-1 Alleviates Acetaminophen—Induced Hepatotoxicity in Alcoholic Fatty Liver Disease by Regulating the Ang II/EGFR/ERK Axis. International Journal of Molecular Sciences. 23(14). 7587–7587. 8 indexed citations
10.
11.
Jiang, Wei, Jiarong Wang, Xin Jiao, et al.. (2021). Caveolin-1 attenuates acetaminophen aggravated lipid accumulation in alcoholic fatty liver by activating mitophagy via the Pink-1/Parkin pathway. European Journal of Pharmacology. 908. 174324–174324. 18 indexed citations
12.
Jiang, Wei, et al.. (2020). Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway. European Journal of Pharmacology. 871. 172910–172910. 38 indexed citations
13.
Hu, Chengmu, et al.. (2019). Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway. European Journal of Pharmacology. 850. 15–22. 39 indexed citations
14.
Cai, Li, Chao Lei, Rong Li, et al.. (2017). Overexpression of aquaporin 4 in articular chondrocytes exacerbates the severity of adjuvant-induced arthritis in rats: an in vivo and in vitro study. Journal of Inflammation. 14(1). 6–6. 22 indexed citations
15.
Li, Rong, Li Cai, Chengmu Hu, Tingni Wu, & Jun Li. (2015). Expression of hedgehog signal pathway in articular cartilage is associated with the severity of cartilage damage in rats with adjuvant-induced arthritis. Journal of Inflammation. 12(1). 24–24. 19 indexed citations
16.
Chen, Yi, et al.. (2014). Lipin Family Proteins - Key Regulators in Lipid Metabolism. Annals of Nutrition and Metabolism. 66(1). 10–18. 63 indexed citations
17.
Cai, Li, et al.. (2012). Therapeutic effect of 7, 3′-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway. International Immunopharmacology. 14(2). 157–163. 29 indexed citations
18.
Wang, Jianqing, Jun Li, Yuhong Zou, et al.. (2008). Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet. Journal of Ethnopharmacology. 121(1). 54–60. 61 indexed citations
19.
Cheng, Wenming, Jun Li, Tianpa You, & Chengmu Hu. (2005). Anti-inflammatory and immunomodulatory activities of the extracts from the inflorescence of Chrysanthemum indicum Linné. Journal of Ethnopharmacology. 101(1-3). 334–337. 165 indexed citations
20.
Chen, Lin, et al.. (2004). Study on anti-inflammatory effects of total flavonoids of litsea coreana Leve. Var. 39(6). 439–442. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mi‐Young Jeong Breakdown of academic impact, for papers by Joe Eun Son Breakdown of academic impact, for papers by Young-Suk Jung Breakdown of academic impact, for papers by Xin Han Breakdown of academic impact, for papers by Mamdouh M. El‐Shishtawy Breakdown of academic impact, for papers by Jinbong Park Breakdown of academic impact, for papers by Laila A. Eissa Breakdown of academic impact, for papers by Yuki Kawakami Breakdown of academic impact, for papers by Zhenping Zhu Breakdown of academic impact, for papers by Yun-Hee Lee
Rankless by CCL
2026